Home
Archives
Jerusalem Center Homepage
View the current issue
Jerusalem Center Videos
Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(Wall Street Journal) Saeed Ghasseminejad and Emanuele Ottolenghi - Investing in Iranian stocks means, primarily, casting your lot with Iran's Islamic Revolutionary Guard Corps, a U.S.-designated terrorist entity. The IRGC presently controls 21% of Tehran Stock Exchange's market value. Investing in a company controlled by a terrorist organization whose record includes murdering Western military personnel and countless civilians isn't just in bad taste. It can also invite serious consequences under anti-terror regulations. Western investors granted exemptions would still be vulnerable to lawsuits by victims of terrorism and their families. Bureaucratic corruption, legalized state robbery and nonexistent rule of law combine to make the Islamic Republic intolerably risky. Investment in Iran isn't just morally dubious and politically problematic. It's also financially unsound. Mr. Ghasseminejad is a doctoral candidate at the City University of New York. Mr. Ottolenghi is a senior fellow at the Foundation for Defense of Democracies. 2014-05-30 00:00:00Full Article
What's Wrong with Investing in Iran?
(Wall Street Journal) Saeed Ghasseminejad and Emanuele Ottolenghi - Investing in Iranian stocks means, primarily, casting your lot with Iran's Islamic Revolutionary Guard Corps, a U.S.-designated terrorist entity. The IRGC presently controls 21% of Tehran Stock Exchange's market value. Investing in a company controlled by a terrorist organization whose record includes murdering Western military personnel and countless civilians isn't just in bad taste. It can also invite serious consequences under anti-terror regulations. Western investors granted exemptions would still be vulnerable to lawsuits by victims of terrorism and their families. Bureaucratic corruption, legalized state robbery and nonexistent rule of law combine to make the Islamic Republic intolerably risky. Investment in Iran isn't just morally dubious and politically problematic. It's also financially unsound. Mr. Ghasseminejad is a doctoral candidate at the City University of New York. Mr. Ottolenghi is a senior fellow at the Foundation for Defense of Democracies. 2014-05-30 00:00:00Full Article
Search Daily Alert
|
Search:
|